Research News
View articles by month and year
-
Study Finds Link Between Certain Genes and Lymphedema Development
A study suggests that certain genes may be linked to developing lymphedema.
-
About 25% of Women Either Don’t Start or Don’t Finish Hormonal Therapy
A study suggests that about 25% of women who are prescribed hormonal therapy to reduce the risk of recurrence after surgery either don’t start taking the medicine or stop taking it early.
-
Study Looks at Relationship Between Drinking and Survival
A study suggests that drinking alcohol before or after being diagnosed with breast cancer doesn’t affect survival. Still, there are some issues with the study.
-
False Positive Mammogram Results Can Cause Long-Term Stress
A study has found that the negative effects of a getting a false positive mammogram result linger for at least 3 years after women learned they didn’t have breast cancer.
-
Abnormal BRCA1 Gene Linked to Worse Outcomes Than Abnormal BRCA2 Gene
A study suggests women with an abnormal BRCA1 gene have worse breast cancer survival and recurrence rates than women with an abnormal BRCA2 gene or women who don’t have either abnormal gene.
-
Nearly Half of Diagnosed Women at High Risk for Abnormal BRCA Genes Not Sent for Testing
A study suggests that about half of newly diagnosed women at high risk for an abnormal breast cancer gene don’t get a genetic testing recommendation from their doctors.
-
Study Suggests Some Women May Be Able to Get Mammograms Every Other Year
A new study suggests that women age 50 to 74 have the same risk of being diagnosed with advanced-stage breast cancer whether they have a mammogram every year or every other year. But women age 40 to 49 with very dense breasts were more likely to be diagnosed with advanced-stage disease if they had mammograms every other year instead of every year.
-
Older Women Who Don’t Get Regular Mammograms Have a Higher Risk of Dying from Breast Cancer
A study found that women 75 and older who didn’t get regular mammograms had a higher risk of dying from breast cancer.
-
Taxol Plus Tykerb Better Than Taxol Alone to Treat HER2-Positive, Metastatic Disease
The combination of Taxol and Tykerb offers more benefits in treating newly diagnosed metastatic, HER2-positive breast cancer than Taxol alone.
-
Healthy Heart Lifestyle Reduces Cancer Risk
People who follow the American Heart Association’s heart health guidelines have a 51% lower risk of developing cancer than people who don’t follow those guidelines.
